tirzepatide substitute Do You Have to Stay on for Life? Treatment Duration Explained Compounded Tirzepatide With B6 (Pyridoxine)

AMG 133 functionally inhibits GIP signalling through human and cynomolgus monkey GIPR with similar potency (half maximal inhibitory concentration (IC 50 ) of 42.4 nM and 26.5 nM, respectively), whereas it has more than 20-fold lower potency for inhibition of GIP signalling through rat GIPR (IC 50 = 822 nM) and did not fully antagonize mouse GIPR with concentrations of up to 3 M

Research suggests that it enhances fibroblast migration, improves cellular survival under stress, and promotes collagen synthesis to support the repair of connective tissue structures

A compounded injection with three components therefore requires three NDC entries on the claim

Tirzepatide's added GIP activity is thought to drive the larger effect on top of the shared GLP-1 pathway though weight loss is only one part of the picture, and semaglutide still has the longer cardiovascular-outcomes track record (more on that below)

Product Highlights 10 mL sterile pharmaceutical-grade nasal spray ~100 sprays per bottle Each spray delivers 0.1 mL 100 mcg total peptide ~50 mcg BPC-157 ~50 mcg TB-500 Total peptide content: 10 mg (5 mg BPC-157 + 5 mg TB-500) Optimized isotonic nasal vehicle for smooth absorption Designed to avoid irritation, dryness, or burning sensation Filled in Class A, lead-free pharmaceutical glass Child-resistant / tamper-proof cap + orifice reducer Preservative-free, high-purity research formulation Benefits Studied for accelerated soft-tissue and cellular repair Explored for tendon, ligament, and muscular healing pathways Research interest in angiogenesis and microcirculation improvement Cytoprotective effects in inflammatory models Potential synergy between BPC-157 + TB-500 in recovery studies Interest in gut, connective-tissue, and neurological resilience Localized Nasal Delivery Effects Rapid mucosal uptake Faster systemic availability in research models Avoids the need for injection-based delivery Smooth, non-irritating isotonic formulation What Researchers Use It For Anti-inflammatory & cytoprotective signaling Angiogenesis and vascular repair modeling Tissue recovery under strain, injury, or oxidative stress Synergistic peptide activity between BPC-157 & TB-500 Regenerative peptide research involving ECM remodeling Identity & Specs BPC-157 (5 mg) Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Formula / M.W.: C62H98N16O22 ~1419.5 g/mol CAS: 137525-51-0 TB-500 (5 mg) (Thymosin Beta-4 fragment) Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Thr-Glu-Glu-Ala-Gln-Gly-Gln-Ala-Gln Formula / M.W.: ~4963 g/mol (varies by analog fragment form) CAS: N/A (fragment analog) General Specs Form: Sterile nasal spray solution Net per vial: 10 mL (~100 sprays) Total Content: 5 mg BPC-157 + 5 mg TB-500 Purity: 99% (HPLC) Identity: MS-verified (per COA) Storage: Refrigerate 28 C, protect from light Selected Research BPC-157 TB-500 / Thymosin Beta-4 Fragment Disclaimer This product is intended for laboratory research use only

The first month on either medication often involves adjustment symptoms, including nausea, reduced appetite that feels uncomfortable rather than liberating, and changes in digestive patterns